Shares of Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF – Get Free Report) shot up 4.8% on Monday . The stock traded as high as $17.63 and last traded at $17.63. 100 shares changed hands during trading, a decline of 90% from the average session volume of 994 shares. The stock had previously closed at $16.83.
Kyowa Kirin Stock Performance
The company has a fifty day simple moving average of $18.07 and a two-hundred day simple moving average of $17.24.
About Kyowa Kirin
Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.
See Also
- Five stocks we like better than Kyowa Kirin
- Russell 2000 Index, How Investors Use it For Profitable Trading
- High-Yield Texas Instruments Could Hit New Highs Soon
- What is the Dogs of the Dow Strategy? Overview and Examples
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- How to Use Stock Screeners to Find Stocks
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Kyowa Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyowa Kirin and related companies with MarketBeat.com's FREE daily email newsletter.
